NDRA
Endra Life Sciences·NASDAQ
--
--(--)
--
--(--)
Signals Analysis
Bullish signal 1
Bearish signal 1
Ample Liquidity
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About NDRA
Endra Life Sciences Inc.
A Healthcare company that develops and commercialize an ultrasound technology for the pre-clinical research market
3600 Green Court
, Suite 350
, Ann Arbor
, MI 48105-1570
Develops an enhanced ultrasound technology platform.
Endra Life Sciences Corporation was incorporated as a Delaware corporation on July 18, 2007. Endra has developed a thermoacoustic effect-based medical imaging technology that significantly improves the sensitivity and specificity of clinical ultrasound. Since 2010, Endra has listed and sold the company's Nexus 128 system based on thermoacoustic and ultrasound imaging combined with light to meet the imaging needs of researchers studying disease models in preclinical applications.
Company Financials
EPS
NDRA has released its 2026 Q2 earnings. EPS was reported at -0.84, versus the expected -0.84, meeting expectations. The chart below visualizes how NDRA has performed over recent quarters, highlighting trends in earnings surprises.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
You can ask Aime
No Data
